{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:04:14Z","timestamp":1790337854616,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Fundaci\u00f3n Burgos por Investigaci\u00f3n de la Salud","award":["Fundaci\u00f3n Burgos por Investigaci\u00f3n de la Salud"],"award-info":[{"award-number":["Fundaci\u00f3n Burgos por Investigaci\u00f3n de la Salud"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00405-026-10477-5","type":"journal-article","created":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T11:53:07Z","timestamp":1785153187000},"page":"6729-6739","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Potential of hTERT mRNA for the management of advanced head and neck squamous cell carcinoma."],"prefix":"10.1007","volume":"283","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0842-4356","authenticated-orcid":false,"given":"Blanca Pilar","family":"Galindo Torres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7501-5798","authenticated-orcid":false,"given":"Raquel","family":"Alcaraz Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7106-5192","authenticated-orcid":false,"given":"Patricia","family":"Saiz L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3265-504X","authenticated-orcid":false,"given":"Mar\u00eda Isabel","family":"Adiego Leza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9384-9649","authenticated-orcid":false,"given":"Carlos","family":"Garc\u00eda Gir\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3956-6007","authenticated-orcid":false,"given":"Miguel V\u00edctor","family":"Grijalba Uche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"10477_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer. J Clin 68:394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492","journal-title":"J Clin"},{"key":"10477_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/154303","volume":"2012","author":"A Amar","year":"2012","unstructured":"Amar A, Chedid HM, Rapoport A et al (2012) Update of Assessment of Survival in Head and Neck Cancer after Regional Recurrence. J Oncol 2012:1\u20134. https:\/\/doi.org\/10.1155\/2012\/154303","journal-title":"J Oncol"},{"key":"10477_CR3","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2019.10665","author":"L Lu","year":"2019","unstructured":"Lu L, Wu Y, Feng M et al (2019) A novel seven\u2013miRNA prognostic model to predict overall survival in head and neck squamous cell carcinoma patients. Mol Med Rep. https:\/\/doi.org\/10.3892\/mmr.2019.10665","journal-title":"Mol Med Rep"},{"key":"10477_CR4","doi-asserted-by":"publisher","first-page":"9557","DOI":"10.18632\/oncotarget.13771","volume":"8","author":"Q Xu","year":"2017","unstructured":"Xu Q, Zhang Q, Ishida Y et al (2017) EGF induces epithelial-mesenchymal transition and cancer stem-like cell properties in human oral cancer cells via promoting Warburg effect. Oncotarget 8:9557\u20139571. https:\/\/doi.org\/10.18632\/oncotarget.13771","journal-title":"Oncotarget"},{"key":"10477_CR5","doi-asserted-by":"publisher","first-page":"vii252","DOI":"10.1093\/annonc\/mdq453","volume":"21","author":"JB Vermorken","year":"2010","unstructured":"Vermorken JB, Specenier P (2010) Optimal treatment for recurrent\/metastatic head and neck cancer. Ann Oncol 21:vii252\u2013vii261. https:\/\/doi.org\/10.1093\/annonc\/mdq453","journal-title":"Ann Oncol"},{"key":"10477_CR6","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.lungcan.2015.01.011","volume":"88","author":"GHMJ Griffioen","year":"2015","unstructured":"Griffioen GHMJ, Louie AV, De Bree R et al (2015) Second primary lung cancers following a diagnosis of primary head and neck cancer. Lung Cancer 88:94\u201399. https:\/\/doi.org\/10.1016\/j.lungcan.2015.01.011","journal-title":"Lung Cancer"},{"key":"10477_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrclinonc.2014.192","volume":"12","author":"H Kang","year":"2015","unstructured":"Kang H, Kiess A, Chung CH (2015) Emerging biomarkers in head and neck cancer in the era of genomics. Nat Rev Clin Oncol 12:11\u201326. https:\/\/doi.org\/10.1038\/nrclinonc.2014.192","journal-title":"Nat Rev Clin Oncol"},{"key":"10477_CR8","doi-asserted-by":"publisher","first-page":"3974","DOI":"10.3390\/cancers17243974","volume":"17","author":"I Morelli","year":"2025","unstructured":"Morelli I, Ghirardini C, Faccani L et al (2025) Liquid Biopsy and Circulating Biomarkers in Head and Neck Cancer: Advancing Non-Invasive Detection and Tailored Management. Cancers 17:3974. https:\/\/doi.org\/10.3390\/cancers17243974","journal-title":"Cancers"},{"key":"10477_CR9","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/jamaoto.2025.4837","volume":"152","author":"DA Ruiz-Torres","year":"2026","unstructured":"Ruiz-Torres DA, Roberts TJ, Du P et al (2026) Prognostic Value of Tumor-Informed Circulating Tumor DNA in HPV\u2013Independent Head and Neck Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg 152:249. https:\/\/doi.org\/10.1001\/jamaoto.2025.4837","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10477_CR10","doi-asserted-by":"publisher","first-page":"e0320485","DOI":"10.1371\/journal.pone.0320485","volume":"20","author":"R Mastronicola","year":"2025","unstructured":"Mastronicola R, Kayser E, Le Roux P et al (2025) Study of the survival of patients with head and neck cancer in relation to Circulating Tumor Cells (CTCs). PLoS ONE 20:e0320485. https:\/\/doi.org\/10.1371\/journal.pone.0320485","journal-title":"PLoS ONE"},{"key":"10477_CR11","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1186\/s12903-025-05898-3","volume":"25","author":"S Mohammad","year":"2025","unstructured":"Mohammad S, Ullah I, Ali A et al (2025) Role of circulating tumor DNA and cell-free DNA biomarkers in diagnosis and prognosis of oral cancer - a systematic review. BMC Oral Health 25:522. https:\/\/doi.org\/10.1186\/s12903-025-05898-3","journal-title":"BMC Oral Health"},{"key":"10477_CR12","doi-asserted-by":"publisher","first-page":"3399","DOI":"10.1007\/s12094-025-03854-9","volume":"27","author":"BP Galindo Torres","year":"2025","unstructured":"Galindo Torres BP, Alcaraz Ortega R, Saiz L\u00f3pez P et al (2025) New evidence for miRNA testing in head and neck squamous cell cancer patients. Clin Transl Oncol 27:3399\u20133409. https:\/\/doi.org\/10.1007\/s12094-025-03854-9","journal-title":"Clin Transl Oncol"},{"key":"10477_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/ncrna9010009","volume":"9","author":"E Broseghini","year":"2023","unstructured":"Broseghini E, Filippini DM, Fabbri L et al (2023) Diagnostic and Prognostic Value of microRNAs in Patients with Laryngeal Cancer: A Systematic Review. Noncoding RNA 9:9. https:\/\/doi.org\/10.3390\/ncrna9010009","journal-title":"Noncoding RNA"},{"key":"10477_CR14","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1126\/science.1138596","volume":"315","author":"SB Cohen","year":"2007","unstructured":"Cohen SB, Graham ME, Lovrecz GO et al (2007) Protein Composition of Catalytically Active Human Telomerase from Immortal Cells. Science 315:1850\u20131853. https:\/\/doi.org\/10.1126\/science.1138596","journal-title":"Science"},{"key":"10477_CR15","doi-asserted-by":"publisher","first-page":"e0133174","DOI":"10.1371\/journal.pone.0133174","volume":"10","author":"C Zhang","year":"2015","unstructured":"Zhang C, Chen X, Li L et al (2015) The Association between Telomere Length and Cancer Prognosis: Evidence from a Meta-Analysis. PLoS ONE 10:e0133174. https:\/\/doi.org\/10.1371\/journal.pone.0133174","journal-title":"PLoS ONE"},{"key":"10477_CR16","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1034\/j.1600-0714.2001.301001.x","volume":"30","author":"MG Downey","year":"2001","unstructured":"Downey MG, Going JJ, Stuart RC, Keith WN (2001) Expression of telomerase RNA in oesophageal and oral cancer. J Oral Pathol Med 30:577\u2013581. https:\/\/doi.org\/10.1034\/j.1600-0714.2001.301001.x","journal-title":"J Oral Pathol Med"},{"key":"10477_CR17","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.oraloncology.2015.02.100","volume":"51","author":"P Boscolo-Rizzo","year":"2015","unstructured":"Boscolo-Rizzo P, Rampazzo E, Perissinotto E et al (2015) Telomere shortening in mucosa surrounding the tumor: Biosensor of field cancerization and prognostic marker of mucosal failure in head and neck squamous cell carcinoma. Oral Oncol 51:500\u2013507. https:\/\/doi.org\/10.1016\/j.oraloncology.2015.02.100","journal-title":"Oral Oncol"},{"key":"10477_CR18","doi-asserted-by":"publisher","first-page":"5811","DOI":"10.1038\/s41388-020-01405-w","volume":"39","author":"AN Guterres","year":"2020","unstructured":"Guterres AN, Villanueva J (2020) Targeting telomerase for cancer therapy. Oncogene 39:5811\u20135824. https:\/\/doi.org\/10.1038\/s41388-020-01405-w","journal-title":"Oncogene"},{"key":"10477_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D (2022) Hallmarks of Cancer: New Dimensions. Cancer Discov 12:31\u201346. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-1059","journal-title":"Cancer Discov"},{"key":"10477_CR20","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3892\/mmr.2017.6590","volume":"16","author":"W Barczak","year":"2017","unstructured":"Barczak W, Suchorska WM, Sobecka A et al (2017) hTERT C250T promoter mutation and telomere length as a molecular markers of cancer progression in patients with head and neck cancer. Mol Med Rep 16:441\u2013446. https:\/\/doi.org\/10.3892\/mmr.2017.6590","journal-title":"Mol Med Rep"},{"key":"10477_CR21","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0929-6646(11)60043-0","volume":"110","author":"C-H Chen","year":"2011","unstructured":"Chen C-H, Chen R-J (2011) Prevalence of Telomerase Activity in Human Cancer. J Formos Med Assoc 110:275\u2013289. https:\/\/doi.org\/10.1016\/S0929-6646(11)60043-0","journal-title":"J Formos Med Assoc"},{"key":"10477_CR22","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1196\/annals.1368.028","volume":"1075","author":"F Das\u00ed","year":"2006","unstructured":"Das\u00ed F, Mart\u00ednez-Rodes P, March JA et al (2006) Real-time quantification of human telomerase reverse transcriptase mRNA in the plasma of patients with prostate cancer. Ann N Y Acad Sci 1075:204\u2013210. https:\/\/doi.org\/10.1196\/annals.1368.028","journal-title":"Ann N Y Acad Sci"},{"key":"10477_CR23","first-page":"3125","volume":"28","author":"Z Kunick\u00e1","year":"2008","unstructured":"Kunick\u00e1 Z, Mucha I, Fajkus J (2008) Telomerase activity in head and neck cancer. Anticancer Res 28:3125\u20133129","journal-title":"Anticancer Res"},{"key":"10477_CR24","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s10555-016-9633-1","volume":"35","author":"P Boscolo-Rizzo","year":"2016","unstructured":"Boscolo-Rizzo P, Da Mosto MC, Rampazzo E et al (2016) Telomeres and telomerase in head and neck squamous cell carcinoma: from pathogenesis to clinical implications. Cancer Metastasis Rev 35:457\u2013474. https:\/\/doi.org\/10.1007\/s10555-016-9633-1","journal-title":"Cancer Metastasis Rev"},{"key":"10477_CR25","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1080\/00016480410024451","volume":"125","author":"Y-R Li","year":"2005","unstructured":"Li Y-R, Wu J-M, Wang L et al (2005) Human telomerase reverse transcriptase expression and its clinical significance in laryngeal squamous cell carcinoma. Acta Otolaryngol 125:409\u2013414. https:\/\/doi.org\/10.1080\/00016480410024451","journal-title":"Acta Otolaryngol"},{"key":"10477_CR26","doi-asserted-by":"publisher","first-page":"7444","DOI":"10.1158\/1078-0432.CCR-08-0478","volume":"14","author":"L Terrin","year":"2008","unstructured":"Terrin L, Rampazzo E, Pucciarelli S et al (2008) Relationship Between Tumor and Plasma Levels of hTERT mRNA in Patients with Colorectal Cancer: Implications for Monitoring of Neoplastic Disease. Clin Cancer Res 14:7444\u20137451. https:\/\/doi.org\/10.1158\/1078-0432.CCR-08-0478","journal-title":"Clin Cancer Res"},{"key":"10477_CR27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1159\/000111706","volume":"72","author":"N Miura","year":"2007","unstructured":"Miura N, Maruyama S, Oyama K et al (2007) Development of a Novel Assay to Quantify Serum Human Telomerase Reverse Transcriptase Messenger RNA and Its Significance as a Tumor Marker for Hepatocellular Carcinoma. Oncology 72:45\u201351. https:\/\/doi.org\/10.1159\/000111706","journal-title":"Oncology"},{"key":"10477_CR28","volume-title":"American Joint Committee on Cancer: AJCC cancer staging manual","author":"TNM Classification","year":"2017","unstructured":"Classification TNM (2017) American Joint Committee on Cancer: AJCC cancer staging manual, 8 edn. Springer, New York. [Google Scholar]","edition":"8"},{"key":"10477_CR29","doi-asserted-by":"publisher","unstructured":"Huang Y-K, Fan X-G, Qiu F, Wang Z-M (2012) Combined Detection of mRNA Expression of Alpha-Fetoprotein in Peripheral Blood and Telomerase Activity of Monocytes in Hepatocellular Carcinoma Patients. https:\/\/doi.org\/10.5754\/hge12359. HGE","DOI":"10.5754\/hge12359"},{"key":"10477_CR30","doi-asserted-by":"publisher","first-page":"R56","DOI":"10.1186\/bcr2893","volume":"13","author":"L Lu","year":"2011","unstructured":"Lu L, Zhang C, Zhu G et al (2011) Telomerase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease outcome. Breast Cancer Res 13:R56. https:\/\/doi.org\/10.1186\/bcr2893","journal-title":"Breast Cancer Res"},{"key":"10477_CR31","doi-asserted-by":"publisher","unstructured":"Lan Q, Cawthon R, Gao Y et al (2013) Longer Telomere Length in Peripheral White Blood Cells Is Associated with Risk of Lung Cancer and the rs2736100 (CLPTM1L-TERT) Polymorphism in a Prospective Cohort Study among Women in China. PLoS ONE 8e59230. https:\/\/doi.org\/10.1371\/journal.pone.0059230","DOI":"10.1371\/journal.pone.0059230"},{"key":"10477_CR32","doi-asserted-by":"publisher","first-page":"e88135","DOI":"10.1371\/journal.pone.0088135","volume":"9","author":"Q Qin","year":"2014","unstructured":"Qin Q, Sun J, Yin J et al (2014) Telomere Length in Peripheral Blood Leukocytes Is Associated with Risk of Colorectal Cancer in Chinese Population. PLoS ONE 9:e88135. https:\/\/doi.org\/10.1371\/journal.pone.0088135","journal-title":"PLoS ONE"},{"key":"10477_CR33","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.3892\/ol.2016.4188","volume":"11","author":"W Barczak","year":"2016","unstructured":"Barczak W, Rozwadowska N, Romaniuk A et al (2016) Telomere length assessment in leukocytes presents potential diagnostic value in patients with breast cancer. Oncol Lett 11:2305\u20132309. https:\/\/doi.org\/10.3892\/ol.2016.4188","journal-title":"Oncol Lett"},{"key":"10477_CR34","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1002\/hed.20615","volume":"29","author":"CT Allen","year":"2007","unstructured":"Allen CT, Ricker JL, Chen Z, Van Waes C (2007) Role of activated nuclear factor-\u03baB in the pathogenesis and therapy of squamous cell carcinoma of the head and neck. Head Neck 29:959\u2013971. https:\/\/doi.org\/10.1002\/hed.20615","journal-title":"Head Neck"},{"key":"10477_CR35","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/bjc.2017.492","volume":"118","author":"E Rampazzo","year":"2018","unstructured":"Rampazzo E, Del Bianco P, Bertorelle R et al (2018) The predictive and prognostic potential of plasma telomerase reverse transcriptase (TERT) RNA in rectal cancer patients. Br J Cancer 118:878\u2013886. https:\/\/doi.org\/10.1038\/bjc.2017.492","journal-title":"Br J Cancer"},{"key":"10477_CR36","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.3390\/biomedicines11061730","volume":"11","author":"O Rotem","year":"2023","unstructured":"Rotem O, Zer A, Yosef L et al (2023) Blood-Derived Exosomal hTERT mRNA in Patients with Lung Cancer: Characterization and Correlation with Response to Therapy. Biomedicines 11:1730. https:\/\/doi.org\/10.3390\/biomedicines11061730","journal-title":"Biomedicines"},{"key":"10477_CR37","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1186\/s12885-017-3471-6","volume":"17","author":"X Fu","year":"2017","unstructured":"Fu X, Shen C, Wang H et al (2017) Joint quantitative measurement of hTERT mRNA in both peripheral blood and circulating tumor cells of patients with nasopharyngeal carcinoma and its clinical significance. BMC Cancer 17:479. https:\/\/doi.org\/10.1186\/s12885-017-3471-6","journal-title":"BMC Cancer"},{"key":"10477_CR38","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/hed.20007","volume":"26","author":"C-T Liao","year":"2004","unstructured":"Liao C-T, Tung-Chieh Chang J, Wang H-M et al (2004) Telomerase as an independent prognostic factor in head and neck squamous cell carcinoma. Head Neck 26:504\u2013512. https:\/\/doi.org\/10.1002\/hed.20007","journal-title":"Head Neck"},{"key":"10477_CR39","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.3389\/fonc.2020.01275","volume":"10","author":"LMRB Arantes","year":"2020","unstructured":"Arantes LMRB, Cruvinel-Carloni A, De Carvalho AC et al (2020) TERT Promoter Mutation C228T Increases Risk for Tumor Recurrence and Death in Head and Neck Cancer Patients. Front Oncol 10:1275. https:\/\/doi.org\/10.3389\/fonc.2020.01275","journal-title":"Front Oncol"},{"key":"10477_CR40","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1097\/01.MP.0000086488.36623.27","volume":"16","author":"B Luzar","year":"2003","unstructured":"Luzar B, Poljak M, Marin IJ, Gale N (2003) Telomerase Reactivation Is an Early Event in Laryngeal Carcinogenesis. Mod Pathol 16:841\u2013848. https:\/\/doi.org\/10.1097\/01.MP.0000086488.36623.27","journal-title":"Mod Pathol"},{"key":"10477_CR41","doi-asserted-by":"publisher","first-page":"6021","DOI":"10.1073\/pnas.1303607110","volume":"110","author":"PJ Killela","year":"2013","unstructured":"Killela PJ, Reitman ZJ, Jiao Y et al (2013) TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci 110:6021\u20136026. https:\/\/doi.org\/10.1073\/pnas.1303607110","journal-title":"Proc Natl Acad Sci"},{"key":"10477_CR42","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/modpathol.3800275","volume":"18","author":"B Luzar","year":"2005","unstructured":"Luzar B, Poljak M, Gale N (2005) Telomerase catalytic subunit in laryngeal carcinogenesis\u2014an immunohistochemical study. Mod Pathol 18:406\u2013411. https:\/\/doi.org\/10.1038\/modpathol.3800275","journal-title":"Mod Pathol"},{"key":"10477_CR43","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.rpor.2019.10.011","volume":"25","author":"MS Ganesh","year":"2020","unstructured":"Ganesh MS, Narayanan GS, Kumar R (2020) Change of telomerase activity in peripheral blood of patients with head and neck squamous cell carcinoma pre and post curative treatment. Rep Practical Oncol Radiotherapy 25:28\u201334. https:\/\/doi.org\/10.1016\/j.rpor.2019.10.011","journal-title":"Rep Practical Oncol Radiotherapy"},{"key":"10477_CR44","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3342\/ceo.2009.2.4.186","volume":"2","author":"D-Y Hong","year":"2009","unstructured":"Hong D-Y, Lee B-J, Lee J-C et al (2009) Expression of VEGF, HGF, IL-6, IL-8, MMP-9, Telomerase in Peripheral Blood of Patients with Head and Neck Squamous Cell Carcinoma. Clin Exp Otorhinolaryngol 2:186. https:\/\/doi.org\/10.3342\/ceo.2009.2.4.186","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"10477_CR45","doi-asserted-by":"publisher","first-page":"e43470","DOI":"10.1371\/journal.pone.0043470","volume":"7","author":"JA March-Villalba","year":"2012","unstructured":"March-Villalba JA, Mart\u00ednez-Jabaloyas JM, Herrero MJ et al (2012) Cell-Free Circulating Plasma hTERT mRNA Is a Useful Marker for Prostate Cancer Diagnosis and Is Associated with Poor Prognosis Tumor Characteristics. PLoS ONE 7:e43470. https:\/\/doi.org\/10.1371\/journal.pone.0043470","journal-title":"PLoS ONE"},{"key":"10477_CR46","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/s10147-012-0405-9","volume":"18","author":"Y Kang","year":"2013","unstructured":"Kang Y, Zhang J, Sun P, Shang J (2013) Circulating cell-free human telomerase reverse transcriptase mRNA in plasma and its potential diagnostic and prognostic value for gastric cancer. Int J Clin Oncol 18:478\u2013486. https:\/\/doi.org\/10.1007\/s10147-012-0405-9","journal-title":"Int J Clin Oncol"},{"key":"10477_CR47","doi-asserted-by":"publisher","first-page":"183","DOI":"10.4103\/0971-5851.190350","volume":"37","author":"A Rai","year":"2016","unstructured":"Rai A, Naikmasur VG, Sattur A (2016) Quantification of telomerase activity in normal oral mucosal tissue and oral squamous cell carcinoma. Indian J Med Pediatr Oncol 37:183\u2013188. https:\/\/doi.org\/10.4103\/0971-5851.190350","journal-title":"Indian J Med Pediatr Oncol"},{"key":"10477_CR48","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1007\/s12094-011-0727-5","volume":"13","author":"YS Lee","year":"2011","unstructured":"Lee YS, Tae K, Lee SH et al (2011) Change of telomerase activity in peripheral whole blood of head and neck squamous cell carcinoma patients before and after surgery: a pilot study. Clin Transl Oncol 13:747\u2013752. https:\/\/doi.org\/10.1007\/s12094-011-0727-5","journal-title":"Clin Transl Oncol"},{"key":"10477_CR49","doi-asserted-by":"publisher","first-page":"17572","DOI":"10.1038\/s41598-019-54028-x","volume":"9","author":"P Boscolo-Rizzo","year":"2019","unstructured":"Boscolo-Rizzo P, Rampazzo E, Polesel J et al (2019) Predictive and prognostic significance of telomerase levels\/telomere length in tissues and peripheral blood in head and neck squamous cell carcinoma. Sci Rep 9:17572. https:\/\/doi.org\/10.1038\/s41598-019-54028-x","journal-title":"Sci Rep"},{"key":"10477_CR50","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1101\/gad.1214704","volume":"18","author":"L Gewin","year":"2004","unstructured":"Gewin L, Myers H, Kiyono T, Galloway DA (2004) Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6\/E6-AP complex. Genes Dev 18:2269\u20132282. https:\/\/doi.org\/10.1101\/gad.1214704","journal-title":"Genes Dev"},{"key":"10477_CR51","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1093\/annonc\/mdx304","volume":"28","author":"M Taberna","year":"2017","unstructured":"Taberna M, Mena M, Pav\u00f3n MA et al (2017) Human papillomavirus-related oropharyngeal cancer. Ann Oncol 28:2386\u20132398. https:\/\/doi.org\/10.1093\/annonc\/mdx304","journal-title":"Ann Oncol"},{"key":"10477_CR52","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ajg.2014.04.001","volume":"15","author":"A El-Mazny","year":"2014","unstructured":"El-Mazny A, Sayed M, Sharaf S (2014) Human telomerase reverse transcriptase messenger RNA (TERT mRNA) as a tumour marker for early detection of hepatocellular carcinoma. Arab J Gastroenterol 15:68\u201371. https:\/\/doi.org\/10.1016\/j.ajg.2014.04.001","journal-title":"Arab J Gastroenterol"},{"key":"10477_CR53","first-page":"549","volume":"55","author":"A Perhavec","year":"2008","unstructured":"Perhavec A, Cerkovnik P, Novakovic S, Zgajnar J (2008) The hTERT mRNA in plasma samples of early breast cancer patients, non-cancer patients and healthy individuals. Neoplasma 55:549\u2013554","journal-title":"Neoplasma"},{"key":"10477_CR54","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00428-005-0087-z","volume":"448","author":"G Pelosi","year":"2006","unstructured":"Pelosi G, Schianchi E, Dell\u2019Orto P et al (2006) Detecting cell-free circulating hTERT mRNA in the plasma may identify a subset of nonsmall cell lung cancer patients. Virchows Arch 448:7\u201315. https:\/\/doi.org\/10.1007\/s00428-005-0087-z","journal-title":"Virchows Arch"},{"key":"10477_CR55","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/j.1600-0714.2004.00232.x","volume":"33","author":"S Koscielny","year":"2004","unstructured":"Koscielny S, Eggeling FV, Dahse R, Fiedler W (2004) The influence of reactivation of the telomerase in tumour tissue on the prognosis of squamous cell carcinomas in the head and neck. J Oral Pathol Med 33:538\u2013542. https:\/\/doi.org\/10.1111\/j.1600-0714.2004.00232.x","journal-title":"J Oral Pathol Med"},{"key":"10477_CR56","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/hed.24638","volume":"39","author":"DC Garc\u00eda-Olmo","year":"2017","unstructured":"Garc\u00eda-Olmo DC, Contreras JD, Picazo MG et al (2017) Potential clinical significance of perioperative levels of mRNA in plasma from patients with cancer of the larynx or hypopharynx: Liquid biopsy in laryngeal cancer. Head Neck 39:647\u2013655. https:\/\/doi.org\/10.1002\/hed.24638","journal-title":"Head Neck"},{"key":"10477_CR57","doi-asserted-by":"publisher","first-page":"815","DOI":"10.58600\/eurjther2517","volume":"30","author":"E Sari","year":"2024","unstructured":"Sari E, Aliyeva A (2024) Correlation of Imaging and Histopathological Findings in Head and Neck Cancer. Eur J Ther 30:815\u2013822. https:\/\/doi.org\/10.58600\/eurjther2517","journal-title":"Eur J Ther"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-026-10477-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-026-10477-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-026-10477-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:56:55Z","timestamp":1790337415000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-026-10477-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":57,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10477"],"URL":"https:\/\/doi.org\/10.1007\/s00405-026-10477-5","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"27 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest. The authors confirm that this manuscript was not previously presented. All authors have read and approved the published version of the manuscript. The authors declare that they have not used any type of generative artificial intelligence for the writing of this manuscript, nor for the creation of images, graphics, tables, or their corresponding captions. The data that support the findings of this study are not openly available and are available from the corresponding author upon reasonable request.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}